ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 186 filers reported holding ARCUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $947,112 | +18.6% | 51,925 | +34.4% | 0.13% | -0.8% |
| Q4 2022 | $798,806 | -47.8% | 38,627 | -34.0% | 0.13% | -44.4% |
| Q3 2022 | $1,531,000 | +118.7% | 58,528 | +111.9% | 0.23% | +274.2% |
| Q2 2022 | $700,000 | +243.1% | 27,618 | +446.8% | 0.06% | +287.5% |
| Q4 2021 | $204,000 | -51.0% | 5,051 | -79.2% | 0.02% | -40.7% |
| Q3 2020 | $416,000 | +76.3% | 24,247 | +42.4% | 0.03% | +42.1% |
| Q1 2020 | $236,000 | +19.2% | 17,033 | -12.9% | 0.02% | +58.3% |
| Q4 2019 | $198,000 | -5.7% | 19,562 | -15.3% | 0.01% | 0.0% |
| Q3 2019 | $210,000 | +57.9% | 23,100 | +38.3% | 0.01% | +50.0% |
| Q2 2019 | $133,000 | – | 16,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |